Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan.
Survival results by the prospectively determined clinical staging for locally advanced gastric cancer: An ancillary study of JCOG1302A (JCOG1302A2). A phase II study of paclitaxel and carboplatin plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results